PCR and Real-time PCR Molecular Diagnostics Market
PCR and Real-time PCR Molecular Diagnostics Market By Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents, Consumables), By Application (Infectious Disease Testing, Oncology Testing, Genetic Testing), By End User (Hospitals, Diagnostic Laboratories, Academic & Research Centers) & Region – Global Market Insights 2023 to 2033
Analysis of PCR and Real-time PCR Molecular Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
PCR and Real-time PCR Molecular Diagnostics Market Outlook (2023 to 2033)
The global PCR and real-time PCR molecular diagnostics market is predicted to progress at a CAGR of 4.1% from 2023 to 2033. The market is valued at US$ 5 billion in 2023 and is thereby expected to reach US$ 7.5 billion by 2033-end.
Testing for infectious diseases is likely to increase as the years go by, attributed to the high prevalence of sexually-transmitted infections, respiratory infections, and hepatitis C and B. The use of polymerase chain reaction (PCR) molecular diagnostics has significantly increased in recent years. When it comes to identifying pathogenic DNA for many communicable diseases, PCR testing is immensely effective. The reach of PCR and RT-PCR tests is being expanded to find cures for serious illnesses.
Demand for advanced PCR tests is increasing due to the high prevalence of infectious diseases and expanding use of biomarker profiling for disease diagnostics. Consumer preferences for early disease identification and treatment have sped up in genetic research, genetic technology development, and product development. Around the world, governments and federal agencies are highlighting the importance of PCR and real-time PCR technology in genomics research.
Small alterations to the enzymes and significant changes in a particular outcome are what essentially drive advancements in PCR and real-time PCR molecular diagnostics. The reliability and accuracy of PCR and real-time PCR molecular diagnostics are now the subjects of extensive research and development efforts, which is a development that is anticipated to support market expansion throughout the projection period.
PCR and real-time PCR molecular diagnostics are becoming more widely used for Pseudomonas aeruginosa identification and detection. This is projected to improve the overall prospects of the worldwide PCR and real-time PCR molecular diagnostics market over the forecast period.
Researchers and medical professionals are still concentrating on new developments in quick, accurate, and efficient medical diagnostics because the current techniques used in molecular biology and medical diagnostics need a lot of time and effort. Since it allows for the replication of a target DNA molecule, PCR and real-time PCR molecular diagnostics have been increasingly popular over the past few decades, making it possible to diagnose a variety of diseases with greater accuracy.
Quantitative PCR and real-time PCR molecular diagnostics are considered to be very stable and reliable medical diagnostics approaches by researchers and stakeholders in the market. Furthermore, since PCR and real-time PCR molecular diagnostics are widely performed in automated thermal cyclers, there is less chance of cross-contamination.
Investments in PCR and real-time PCR molecular diagnostics have grown steadily. Additionally, based on recent studies, the trend is expected to continue over the coming years due to the enormous potential of PCR and real-time PCR molecular diagnostics.
PCR and Real-time PCR Molecular Diagnostics Market Size (2023)
US$ 5 Billion
Projected Market Value (2033)
US$ 7.5 Billion
Global Market Growth Rate (2023 to 2033)
Market Share of Digital PCR
Key Companies Profiled
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors Will Shape PCR and Real-time PCR Molecular Diagnostics Market Evolution?
“Elevated Global Burden of Infectious and Chronic Ailments”
Demand for PCR & real-time PCR tests is increasing as governments from different countries across the world progressively provide financial and policy-driven assistance to key market participants. PCR & real-time PCR molecular diagnostics are rapid and have a lesser chance of cross-contamination than alternative viral isolation methods.
It is expected that rising cancer and infectious illness prevalence would drive the market. The market is anticipated to grow as a result of regulatory approvals, technological advancements, and growth in the use of molecular diagnostic tools for infectious and cancerous disorders.
The management of cancer is significantly influenced by early identification. A variety of technologies are available in molecular diagnostics for the precise and trustworthy diagnosis of diseases. Additionally, PCR-based systems improve workflow to lower costs overall and do away with the requirement for additional systems.
PCR and RT-PCR tests are gaining a lot of momentum as the high prevalence of infectious and chronic diseases. As a result, RT-PCR tests have been very effective in detecting multiple microtumor cells that are circulating in the human body. These tests aid in precise prognosis and forecast chemotherapy toxicity, resistance, or response.
“High Demand for Advanced Molecular Diagnostics”
The rising complexities of chronic and infectious diseases are driving the demand for enhanced diagnostic technologies. To control and stop the spread of diseases such as cancer, early detection is essential.
Advanced molecular diagnostics are becoming more popular due to clinical advantages such as increased sensitivity, wider use, and quick response times. Based on this trend, demand for PCR and RT-PCR tests is expected to increase over the coming years.
What is Restraining Global Demand for PCR and Real-time PCR Molecular Diagnostic Tools?
“High Cost of PCR & Real-time PCR Molecular Diagnostic Instruments and Technological Restrictions on PCR”
The high cost of PCR and real-time PCR molecular diagnostic instruments and technological restrictions related to PCR are the elements anticipated to hamper industry expansion. Pricing trends indicate that the total cost is increased by the variable costs of the required chemicals and those fixed by their suppliers. Other expenditures include maintenance and insurance, laboratory supervision, and overhead.
Only major hospitals and reference labs with good capital budgets may be able to afford the high volume of molecular diagnostic equipment. With no capital expenditures, the majority of small labs, medical practices, and solo practitioners might not be able to buy a large or extremely large-sized analyzer. Therefore, high-cost requirements could limit market growth.
Why is North America Dominating the Global Market for PCR and Real-time PCR Molecular Diagnostics?
“Rapid Expansion of Molecular Diagnostics Sector”
North America is expected to remain promising and hold 60% share of the global market owing to multiple product launches and a burgeoning healthcare industry. Regulatory approvals by the FDA, technological advancements, and rapid expansion of the molecular diagnostics sector are the main forces driving market growth in the region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is the Demand Outlook for PCR and Real-time PCR Molecular Diagnostics in the United States?
“Growing Prevalence of Genetic Diseases in the Country”
Market expansion in the United States is attributed to the increased adoption of advanced genomic analysis tools, favorable legislation, government-led activities to build the healthcare infrastructure, and the accessibility of R&D grants. The growing prevalence of genetic diseases and the substantial presence of well-known companies are boosting market value in the United States.
Why is Germany a Prominent Market for PCR and Real-time PCR Molecular Diagnostics?
“Surging Adoption of Most Recent PCR Technology Systems”
The market in Germany is anticipated to expand at a profitable rate during the projection period owing to the high standard of living, ongoing cost reductions for gene sequencing, and growing consumer awareness of early disease diagnosis.
An increase in government funding for PCR and RT-PCR technologies, the quick adoption of the most recent PCR technology systems, and great emphasis on research and development activities are boosting market growth in Germany.
What Makes Japan Stand Out in the Asia Pacific Market?
“Rising Demand for Rapid Diagnostic Tests across Japan”
Rapid integration of PCR techniques, a high proportion of the geriatric population and consequent rise in chronic & infectious ailments, huge demand for rapid diagnostic tests, and growing regional outsourcing of research and clinical trials are supporting market expansion in Japan. Timely detection of HIV/AIDS, cancer, and hepatitis have accelerated the need for adopting accurate RT-PCR testing kits in Japan.
Which Technology is Forecast to Gain a Leading Market Share?
“Digital PCR Techniques Gaining Traction Owing to Their High Adoption in Clinical Research & Drug Development”
By the technology, the market is segmented into traditional PCR, real-time PCR, and digital PCR. Digital PCR techniques account for 50% share of the global market owing to their growing usage in clinical research and drug development due to absolute detection and lower reagent use.
Next-generation diagnostic tool for accurate nucleic acid measurement is digital PCR. Due to the high sensitivity and accuracy of these systems compared to other PCR-based techniques, the demand for digital PCR techniques is increasing.
Which End User Will Emerge as a Key Market Contributor?
“Hospitals More Preferred Due to Easy Accessibility of Various Diagnostic & Treatment Facilities”
Based on end user, the market is divided into hospitals, diagnostic laboratories, and academic & research centers. Hospitals hold 40% share of the global market due to a rising focus on delivering high-quality healthcare, increased emphasis on disease early diagnosis, and an increase in specialty hospitals with modern facilities.
Hospitals will continue to be the main end users of PCR molecular diagnostic technology due to patients' strong preference for seeking expert treatment. Hospitals are equipped with the trained staff required to perform complex tests and deliver accurate findings. The use of PCR and real-time PCR molecular diagnostic techniques in hospitals is being facilitated by the availability of highly qualified healthcare personnel as well as a variety of diagnostic and treatment facilities.
Leading companies in the global PCR and real-time PCR molecular diagnostics market are focusing on the local supply of diagnostic tools, safety regulations, and product standards to remain afloat. They are also making collaborations with other players, government agencies, and research institutes to deepen their geographical presence.
Top market players are concentrating on quality control by introducing advanced testing kits to lower the environmental impact. Key PCR and real-time PCR molecular diagnostic device providers should focus on supply chain management to gain a competitive edge in the market.
For instance :
- Abbott Laboratories received an emergency use authorization (EUA) from the U.S. FDA to introduce its RealTime SARS-CoV-2 assay based on PCR for qualitative nucleic acid detection.
- In March 2020, Bio-Rad Laboratories partnered with testing labs worldwide to develop and implement RT-PCR products for the detection of novel coronavirus. The extensive use of these products is the Assurance Scientific Laboratories in Birmingham, Alabama. It uses Bio-Rad’s CFX384 Touch Real-Time PCR Detection Systems.
Segmentation of PCR and Real-time PCR Molecular Diagnostics Industry Research
By Technology :
- Traditional PCR
- Real-time PCR
- Digital PCR
By Product :
By Application :
- Infectious Disease Testing
- Oncology Testing
- Genetic Testing
By End User :
- Diagnostic Laboratories
- Academic & Research Centers
By Region :
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- FAQs -
Global demand for PCR and real-time PCR molecular diagnostic instruments is set to increase at a CAGR of 4.1% through 2033.
Adoption of PCR and real-time PCR molecular diagnostic devices is set to reach US$ 7.5 billion by 2033.
Digital PCR holds 50% share of the global PCR and real-time PCR molecular diagnostics market.
The United States, Germany, and Japan are key countries boosting the sales of PCR and real-time PCR molecular diagnostic tools.
Abbott Laboratories, Bio-Rad Laboratories, and Danaher Corporation are key players in the market.